Picture of AxoGen logo

AXGN — AxoGen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

AxoGen Inc reports results for the quarter ended in September - Earnings Summary

* AxoGen Inc  AXGN.OQ  reported a quarterly adjusted loss of
1
cent​​ per share for the quarter ended in September. The mean
expectation of six analysts for the quarter was for a loss of 12
cents per share.
    * Revenue rose 18.4% to $36.96 million from a year ago;
analysts
expected $36.19 million. 
    * AxoGen Inc's reported EPS for the quarter was a loss of 10
cents​.
    * The mean earnings estimate of analysts had fallen by
about 11.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * AxoGen Inc shares had fallen by 10.4% this quarter and
gained 14.0% so far this year.
    * The company reported a quarterly loss of $4.32 million.
    * Wall Street's median 12-month price target for AxoGen Inc
is
$20.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 02:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.12          -0.01          Beat
 Jun. 30 2022      -0.14          -0.06          Beat
 Mar. 31 2022      -0.15          -0.20          Missed
 Dec. 31 2021      -0.13          -0.08          Beat

Recent news on AxoGen

See all news